✦ LIBER ✦

Infliximab in the treatment of Crohn’s disease: is it a steroid sparing agent or a steroid replacing agent?

✍ Scribed by Mark R. Fleisher; Steven D. Rubin; Andrew E. Levine; Alexander Burns; Kyle Etzkom; Ruby J. Turner; Katherine Hopkins

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Steroids vs. infliximab in the treatment

✍ Mark R Fleisher; Steven D Rubin; Andrew E Levine; Alexander W.R Burns 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 22 KB

Infliximab as a steroid-sparing agent in

✍ Thomas Sené; Caroline Juillard; Michel Rybojad; Florence Cordoliani; Céleste Leb 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 291 KB

P421 Prevalence of steroid dependence an

✍ Cassieri, C.; De Carolis, A.; Pica, R.; Avallone, E.V.; Zippi, M.; Corrado, C.; 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 67 KB

P.08.19 PREVALENCE OF STEROID DEPENDENCE

✍ Cassieri, C.; De Carolis, A.; Pica, R.; Avallone, E.V.; Zippi, M.; Corrado, C.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Pemphigus vulgaris: Results of treatment

✍ Poulin, Yves; Perry, Harold O.; Muller, Sigfrid A. 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 640 KB

OBSERVATIONS ON THE MECHANISM OF OMALIZU

✍ Dreyfus, David H. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB